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Abstract
Background: The human hepatitis B virus (HBV), a member of the hepadna viridae, causes acute or chronic
hepatitis B, and hepatocellular carcinoma (HCC). The duck hepatitis B virus (DHBV) infection, a dependable and
reproducible model for hepadna viral studies, does not result in HCC unlike chronic HBV infection. Information on
differential gene expression in DHBV infection might help to compare corresponding changes during HBV
infection, and to delineate the reasons for this difference.
Findings: A subtractive hybridization cDNA library screening of in vitro DHBV infected, cultured primary duck
hepatocytes (PDH) identified cDNAs of 42 up-regulated and 36 down-regulated genes coding for proteins associated
with signal transduction, cellular respiration, transcription, translation, ubiquitin/proteasome pathway, apoptosis, and
membrane and cytoskeletal organization. Those coding for both novel as well as previously reported proteins in
HBV/DHBV infection were present in the library. An inverse modulation of the cDNAs of ten proteins, reported to play
role in human HCC, such as that of Y-box binding protein1, Platelet-activating factor acetylhydrolase isoform 1B,
ribosomal protein L35a, Ferritin, a-enolase, Acid a-glucosidase and Caspase 3, copper-zinc superoxide dismutase
(CuZnSOD), Filamin and Pyruvate dehydrogenase, was also observed in this in vitro study.
Conclusions: The present study identified cDNAs of a number of genes that are differentially modulated in in vitro
DHBV infection of primary duck hepatocytes. Further correlation of this differential gene expression in in vivo
infection models would be valuable to understand the little known aspects of the hepadnavirus biology.
Introduction
The human hepatitis B virus (HBV) and the duck hepati-
tis B virus (DHBV), which are members of the same virus
family, hepadnaviridae, share several features in common
[1]. Unavailability of primary animal models susceptible
to HBV infection, and inefficiency and unreliability of the
infection process in in vitro systems [2] are major limita-
tions in HBV research which restrain the study of this
major human pathogen. But the establishment of the ani-
mal model with domestic duck employing the DHBV has
helped greatly to overcome the shortcomings in HBV
research [1,3]. However, this model has its own limita-
tions as revealed by the differences in the clinical mani-
festations of the disease in humans and birds infected by
these viruses. This mainly pertains to the chronicity in
DHBV infection without liver injury/hepatocellular carci-
noma (HCC)/cirrhosis; spontaneous elimination of infec-
tion in adult ducks; and at the molecular level, the
expression of only a cryptic X-protein [4]. A major
lacuna in HBV biology is the lack of sufficient informa-
tion on the molecular mechanisms involved in the devel-
opment of HCC in chronic HBV patients, which has
become a major medical challenge [5].
A few studies have been performed comparing the gene
expression in HBV positive HCC and non-cancerous liver
[6] and viral and non-viral HCC [7] in patient samples.
However, no study has focused to identify the differential
gene expression in infection with DHBV either in vivo or
in vitro to facilitate a comparative analysis. A recent in
vitro study has addressed the proteomic changes during
DHBV infection, which has brought to light a number of
genes that are involved in the infection process [8]. How-
ever, a purely proteome based approach might not reveal
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any medium, provided the original work is properly cited.changes in the expression levels of many of the low abun-
dant proteins due to technical limitations, which needs to
be complemented by mRNA/cDNA differential expres-
sion based approaches. In this context, we carried out a
subtractive hybridization cDNA library construction and
screening to identify the differential gene expression dur-
ing DHBV infection in primary duck hepatocytes (PDH)
in culture. The protocol we followed identified 42 up-
regulated and 36 down-regulated genes in DHBV
infected PDH in culture.
Methods
Primary duck hepatocytes (PDH) were isolated from 27-
day old embryonated, un-hatched, duck eggs free of
duck hepatitis B virus (DHBV) infection as previously
d e s c r i b e d[ 9 ]a n dm a i n t a i n e da t5×1 0
6 cells/ml in
DMEM+F12 (Sigma) and 5% FBS supplemented with
glucose (0.5 gm/l), dexamethasone (10
-5 M) and insulin
(1 μg / m l )( a l lf r o mS i g m a )a t3 7 ° Ci na5 %C O 2 atmo-
sphere. DHBV stock was concentrated from LMH-D2
cell culture supernatant, a chicken hepatoma cell line
that constitutively replicate DHBV, (a kind gift from Dr.
William S Mason, Fox Chase Cancer Centre, California),
by precipitation with 10% polyethylene glycol 8000
(USB, USA) [10]. The pellet was re-suspended in
DMEM+F12 medium and this concentrated virus was
used to infect PDH at an MOI of 10
3 genome equiva-
lents per hepatocyte, as previously described [11] in pre-
sence of 1% DMSO (Sigma). DHBV infection was
confirmed by PCR on the DNA obtained from the cul-
ture supernatant using DHBV specific primers P1F and
D2R (Additional File 1, Table 1).
2 μg of polyA RNA each from DHBV infected and unin-
fected PDH on zero and 4
th day of infection was isolated
using PolyATract mRNA isolation system-III (Promega,
USA) and was used to construct forward and reverse
subtracted cDNA libraries using Clontech PCR-Select
cDNA subtraction kit (Clontech, USA), as per kit proto-
cols. PCR amplification of a house-keeping gene
GAPDH (Additional File 1, Table 1) from subtracted
and un-subtracted samples was used for confirmation of
the subtraction efficiency. The subtracted cDNAs were
ligated with the pGEM-T (Easy) vector (Promega), com-
petent JM109 Escherichia coli cells (Promega) were
transformed and plasmids were isolated following stan-
dard molecular biology protocols to obtain 137 forward
and 148 reverse subtracted clones.
Macroarrays of these plasmids were generated by
vacuum transferring 100 ng each of the denatured clone
plasmid in duplicate spots onto nylon membranes
(Hybond-N+, Amersham Biosciences UK) using a dot-
blot apparatus (Bio-Dot, Bio-Rad). The arrays were
hybridized with a
32 P labelled forward and reverse sub-
tracted cDNA mixtures as radioactive probes in a
reverse-northern procedure. The probes were radio-
labelled in a 50 μl PCR reaction using [a
32 P]-dCTP,
dATP, dGTP, dTTP (0.2 mM each) and unlabelled
dCTP (0.02 mM) using the nested PCR primers 1 and
2R (10 μM each) (Additional File 1, Table 1) and the
Advantage 2 polymerase mix (Clontech). The adaptor
regions common to both the probe and library clones
were removed by digestion with RsaI restriction enzyme
(NEB). The arrays were individually hybridized with
both forward and reverse radio-labelled probes. Subse-
quent to a pre-hybridization of the membrane for 30
min in the hybridization solution(10% Polyethylene gly-
col, 1.5× SSPE and 7% sodium dodecyl sulphate), heat
denatured probe solution containing 100 μlo fR s a I
digested radio-labelled probe, 250 μlo f1 0m g / m lH e r -
ring sperm DNA(Promega) and 100 μlo f0 . 2 NN a O H
was added. The probe solution was removed after 16
hrs of hybridization at 65°C and the membrane was
washed twice in 2× SSC and 0.1%SDS for 10 min at
room temperature followed by two high stringency
washes using 0.2× SSC and 0.1%SDS at 65°C for 10 min,
and exposure to a phosphor screen for 30 min. The
images were captured in Molecular Imager FX (Bio-
Rad). The hybridization intensity was measured in the
captured images by densitometry analysis of the signal
on individual clones using VisionWorksLS image acqui-
sition and analysis software( U V P ,U S A ) .T h er e l a t i v e
abundance ratio of gene expression was calculated using
the following formulas.
Abundance Ratio

Up − regulated clones

=
Signal Intensity when hybridized with forward subtracted library probe
Signal Intensity when hybridized with reverse subtracted library probe
Abundance Ratio

down − regulated clones

=
Signal Intensity when hybridized with reverse subtracted library probe
Signal Intensity when hybridized with forward subtracted library probe
All genes with an abundance ratio of more than one, a
cut-off fixed arbitrarily, were then short-listed as the
ones with true differential expression. These clones were
subjected to automated DNA sequencing in an ABI
Prism 310 sequencer (Applied Biosystems) with the Big
Dye Terminator 3.0 kit (ABI Prism; Applied Biosystems)
as per the manufacturer’sd i r e c t i o n su s i n gt h ep r i m e r s
TvectF and TvectR (Additional File 1, Table 1). The
sequences thus obtained were analyzed using the
BLAST online software (NCBI).
Three genes, randomly selected from the top five
genes in Table 1 and 2 (with high abundance); one gene
from the bottom (with lower abundance) of the table;
and one gene, which was not short-listed, were used for
real-time PCR analysis for validation of the short-listing
procedure. Specific primers for these 10 genes (five
from each of the up-regulated and down-regulated
library) and primers for the house keeping gene
GAPDH were designed (Additional File 1, Table 1) and
used in the real-time PCR. cDNA was synthesized using
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Page 2 of 11Table 1 List of cDNAs up-regulated during PDH infection with DHBV
No. Name of the
clone
Abundance
Ratio
BLAST Result BLAST/
tBLASTx
Amplicon Size
(bp)
e-value GenBank Accession
No.
1 F22 2.41 Cadherin 11, type 2, OB-
cadherin (osteoblast)
(CDH11)-Gallus gallus
BLAST 462 0 JG662697
2 F125 2.23 Pyruvate dehydrogenase E1-
beta subunit variant 3-like-
Taeniopygia guttata
BLAST 268 2.00E-85 JG662698
3 F106 2.08 Anas platyrhynchos female-
specific sequence
tBLASTx 371 3.00E-04 JG662699
4 F8 2.04 Similar to SH3 domain
containing 19-Taeniopygia
guttata
tBLASTx 678 4.00E-07 JG662700
5 F71 2 Ubiquitin-like, containing
PHD and RING finger
domains, 1 (UHRF1)-Gallus
gallus
BLAST 593 0 JG662701
6 F21 1.87 Zinc finger CCCH-type
containing 13 (ZC3H13)-
Gallus gallus
BLAST 681 0 JG662702
7 F13 1.77 Succinate-CoA ligase, GDP-
forming, alpha subunit
(SUCLG1)-Gallus gallus
BLAST 767 0 JG662703
8 F76 1.76 ElaC homolog 2 (E. coli)
(ELAC2)-Gallus gallus
tBLASTx 218 1.00E-14 JG662704
9 F19 1.58 CWC22 spliceosome-
associated protein homolog-
Taeniopygia guttata
BLAST 680 0 JG662705
10 F70 1.55 Similar to KIAA2019 protein/
AHNAK nucleoprotein 2-
Gallus gallus
BLAST 544 1.00E-
150
JG662706
11 F46 1.51 Filamin B, beta-Gallus gallus BLAST 655 1.00E-
140
JG662707
12 F77 1.45 Tumor necrosis factor
receptor superfamily,member
6b, decoy (TNFRSF6B)-Gallus
gallus
tBLASTx 527 5.00E-07 JG662708
13 F131 1.44 Nuclear protein Matrin 3
(MATR3)-Gallus gallus
BLAST 448 0 JG662709
14 F45 1.42 Heat shock transcription
factor 2 (HSF2)-Gallus gallus
BLAST 755 0 JG662710
15 F74 1.42 High mobility group AT-hook
2 (HMGA2)-Gallus gallus
BLAST 209 2.00E-49 JG662711
16 F6 1.4 CLE7-Gallus gallus BLAST 541 0 JG662712
17 F16 1.35 Cu/Zn superoxide dismutase
(SOD1)-Melopsittacus
undulatus
BLAST 346 8.00E-31 JG662713
18 F43 1.33 Exonuclease NEF-sp-Gallus
gallus
BLAST 680 9.00E-
143
JG662714
19 F26 1.32 Component of oligomeric
golgi complex 3 (COG3)-Bos
taurus
tBLASTx 308 0.002 JG662715
20 F42 1.31 CD9 protein-Anas
platyrhynchos
BLAST 748 0 JG662716
21 F127 1.31 Junco hyemalis 164 gene,
partial sequence
tBLASTx 234 5.00E-16 JG662717
22 F17 1.29 Quaking homolog, KH
domain-Taeniopygia guttata
BLAST 678 0 JG662718
23 F44 1.29 Alanine-glyoxylate
aminotransferase 2-Gallus
gallus
tBLASTx 721 5.00E-21 JG662719
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Page 3 of 11total RNA from fresh sets of primary duck hepatocyte
cultures either infected with DHBV or uninfected, as
described above, using Avian Myeloblastosis Virus
(AMV) reverse transcription system (Promega). Real-
time PCR was carried out as previously described [12].
The experiments were repeated thrice, each in dupli-
cates, and average fold change in gene expression was
calculated for individual genes.
The threshold cycle (Ct) values obtained in the real-
time PCR analysis were normalized with the expression
of the house-keeping gene GAPDH, and the relative
expression of individual genes in infected and uninfected
cells were calculated by Pfaffl method [13] for Day 0
and Day 4 of infection using the equation:
Ratio =
(Etarget)
CT,target(calibrator-test)
(Eref)
CT,ref(calibrator-test)
The ratios for day 0 and day 4 infected samples were
compared and analysed statistically by paired Student’s
t-test to validate the significance of gene expression
changes. P-values < 0.05 were considered significant.
Table 1 List of cDNAs up-regulated during PDH infection with DHBV (Continued)
24 F135 1.27 Leucine-rich repeats and
calponin homology (CH)
domain containing 4-
Oryctolagus cuniculus
tBLASTx 288 0.4 JG662720
25 F14 1.24 Clathrin, light chain A (CLTA)-
Gallus gallus
BLAST 673 0 JG662721
26 F83 1.2 Sequestosome 1-Gallus gallus BLAST 562 0 JG662722
27 F10 1.18 RAB 32, member of Ras
oncogene-Gallus gallus
BLAST 743 0 JG662723
28 F30 1.16 Ribosomal protein L6 (RPL6)-
Gallus gallus
BLAST 591 0 JG662724
29 F64 1.16 Holocytochrome c synthase
(cytochrome c heme-lyase)-
Gallus gallus
tBLASTx 421 8.00E-52 JG662725
30 F32 1.16 Lysosomal-associated
membrane protein 1-
Taeniopygia guttata
tBLASTx 591 4.00E-93 JG662726
31 F7 1.14 Serine protease 23-Gallus
gallus
BLAST 740 3.00E-
168
JG662727
32 F18 1.09 Beta-catenin isolate 3-Anas
platyrhynchos
BLAST 710 0 JG662728
33 F52 1.09 Zebrafish DNA sequence
from clone CH211-276C22 in
linkage group 6
tBLASTx 218 2.2 JG662729
34 F25 1.08 Gallus gallus finished cDNA,
clone ChEST457d18
tBLASTx 696 2.00E-27 JG662730
35 F59 1.07 Leucine proline-enriched
proteoglycan (leprecan)1/
prolyl 3-hydroxylase 1
(P3H1)-Gallus gallus
BLAST 581 0 JG662731
36 F12 1.07 Ribophorin I-Gallus gallus BLAST 796 0 JG662732
37 F87 1.06 Gallus gallus finished cDNA,
clone ChEST855m19
BLAST 505 3.00E-91 JG662733
38 F95 1.06 Spastic paraplegia 3A
(autosomal dominant)-Gallus
gallus
BLAST 316 3.00E-54 JG662734
39 F107 1.06 High-mobility group box 3-
Taeniopygia guttata
BLAST 276 2.00E-
136
JG662735
40 F1 1.05 ATP synthase, H+
transporting, mitochondrial
F0 complex, subunit F2
(ATP5J2)-Gallus gallus
tBLASTx 199 9.00E-18 JG662736
41 F78 1.03 Ubiquitin specific peptidase
47 (USP47)-Gallus gallus
BLAST 695 0 JG662737
42 F88 1.03 No significant similarity
found
tBLASTx 360 - JG662738
Nair et al. Virology Journal 2011, 8:363
http://www.virologyj.com/content/8/1/363
Page 4 of 11Table 2 List of cDNAs down-regulated during PDH infection with DHBV
No. Name of the clone Abundance Ratio BLAST Result BLAST/
tBLASTx
Amplicon Size (bp) e-value GenBank Accession No.
1 R73 1.52 Ferritin, heavy polypeptide 1
(FTH1)-Gallus gallus
BLAST 342 4.00E-143 JG662661
2 R90 1.41 Zinc finger CCCH-type,
antiviral 1 (ZC3HAV1)-Gallus
gallus
tBLASTx 328 1.00E-14 JG662662
3 R130 1.39 T-complex 1-Taeniopygia
guttata
BLAST 400 6.00E-172 JG662663
4 R108 1.39 Y box binding protein 1-
Gallus gallus
BLAST 486 0 JG662664
5 R96 1.34 MYST/Esa1-associated factor
6-Taeniopygia guttata
BLAST 646 1.00E-17 JG662665
6 R97 1.33 Similar to RGD-CAP-Gallus
gallus
BLAST 743 0 JG662666
7 R111 1.31 PREDICTED: Gallus gallus
similar to Ankycorbin
BLAST 646 0 JG662667
8 R134 1.3 No significant similarity
found
tBLASTx 490 - JG662668
9 R123 1.25 ATPase8, ATPase6 genes for
F0-ATP synthase subunit 8,
F0-ATP synthase subunit 6-
Anas platyrhynchos
BLAST 462 0 JG662669
10 R133 1.24 Versican-Gallus gallus BLAST 257 3.00E-98 JG662670
11 R103 1.22 Platelet-activating factor
acetylhydrolase isoform Ib,
alpha subunit 45kDa
(PAFAH1B1)-Gallus gallus
BLAST 508 4.00E-145 JG662671
12 R16 1.18 UPF0308 protein-Gallus gallus BLAST 593 0 JG662672
13 R100 1.17 TRAF interacting protein
(TRAIP)-Gallus gallus
BLAST 631 0 JG662673
14 R84 1.16 Acid alpha-glucosidase-
Macaca mulatta
tBLASTx 756 3.8 JG662674
15 R15 1.15 Microtubule-associated
protein RP/EB family,
member 1-Taeniopygia
guttata
BLAST 438 5.00E-168 JG662675
16 R126 1.15 Catechol-O-
methyltransferase-Gallus
gallus
tBLASTx 395 1.00E-25 JG662676
17 R135 1.14 Chromosome 15 hypothetical
ATG/GTP binding protein-
Gallus gallus
tBLASTx 239 0.048 JG662677
18 R143 1.13 Ankyrin repeat domain 17
(ANKRD17)-Gallus gallus
BLAST 546 0 JG662678
19 R45 1.13 Splicing factor, arginine/
serine-rich 18 (SFRS18)-Gallus
gallus
tBLASTx 476 1.00E-145 JG662679
20 R141 1.11 Cytochrome oxidase subunit
I (COI)-Anas platyrhynchos
BLAST 336 1.00E-152 JG662680
21 R10 1.11 Eukaryotic translation
initiation factor 5 (EIF5)-Gallus
gallus
BLAST 735 0 JG662681
22 R129 1.11 Beta-actin-Anas
platyrhynchos
BLAST 664 0 JG662682
23 R106 1.1 Alpha enolase-Peking Duck BLAST 381 0 JG662683
24 R93 1.1 No significant similarity
found
tBLASTx 488 - JG662684
25 R139 1.1 Similar to KIAA1824 protein/
WD repeat domain 22-Gallus
gallus
BLAST 279 7.00E-100 JG662685
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Page 5 of 11Results & Discussion
The infection of PDH with DHBV did not produce any
visible changes on the cell monolayer (Figure 1A). The
virus infection was confirmed by PCR detection of a
300 bp DHBV glycoprotein 1 (gp1) gene fragment in the
DNA isolated from infected PDH culture supernatant
(Figure 1B) and by sequence analysis. The establishment
of a productive infection was indicated by the increasing
PCR amplification intensity of the gene fragment with
every successive day of culture for the total culture per-
iod of eight days. For RNA isolation for subtraction
library construction, we selected an early time point of 4
days as described in previous studies [14]. Two libraries
were generated- the forward subtracted or up-regulated
genes and the reverse subtracted or down-regulated
genes. The efficiency of subtraction procedure was indi-
cated by a decrease in the intensity and appearance of
discrete banding patterns in the lanes with subtracted
products (Figure 1C) and was confirmed by PCR detec-
tion of the house-keeping gene GAPDH, the amplicons
of which appeared at an earlier time point (25 cycles) in
un-subtracted samples compared to a later time point
(30 cycles) in both forward and reverse subtracted
libraries (Figure 1D). Hybridization of macroarrays
blotted with 137 up-regulated and 148 down-regulated
clones (Figure 1E) and short-listing only the ones with an
abundance ratio of more than 1, we obtained 42 non-
redundant up-regulated clones and 36 non-redundant
down-regulated clones (Tables 1 and 2). Real-time PCR
done using the representative sets of short-listed clones
gave results confirming the reliability of the short-listing
procedure. Genes that topped the differential expression
among the up-regulated genes (F22, F8, F71) showed a
significant (P < 0.05) increasei ne x p r e s s i o na t4 - d a y s
compared to the 0 day in infected PDH (Figure 2A),
while the reverse was the case of the down-regulated
genes (R73, R90, R130) (Figure 2B), all of whose expres-
sion decreased significantly (P < 0.05) at 4-day DHBV
infection. F88 and R86, which were selected from the
bottom end of the up-regulated and down-regulated
gene-tables, respectively, also showed the expected mod-
ulation albeit at a lower fold. F62 and R47, picked from
the genes left-out did not show any significant difference
in their expression pattern.
Functional classification of the short-listed clones
using gene ontology based on BLAST results grouped
them mainly into those belonging to cellular processes
such as cellular respiration, signal transduction, tran-
scription/translation, ubiquitin/proteasome pathway and
apoptosis besides those coding for membrane and cytos-
keletal proteins (Table 3). Among them, the category
that was maximum up-regulated were the ones involved
Table 2 List of cDNAs down-regulated during PDH infection with DHBV (Continued)
26 R104 1.09 Caspase 3, apoptosis-related
cysteine peptidase (CASP3)-
Gallus gallus
BLAST 792 0 JG662686
27 R95 1.09 Gallus gallus finished cDNA,
clone ChEST757h13
tBLASTx 793 5.00E-19 JG662687
28 R79 1.07 Ral guanine nucleotide
dissociation stimulator-like 1
(RGL1)-Gallus gallus
BLAST 333 1.00E-132 JG662688
29 R105 1.06 Gallus gallus similar to
MGC53471 protein
BLAST 646 7.00E-89 JG662689
30 R128 1.05 Hydroxyacyl glutathione
hydrolase-like,transcript
variant 2-Taeniopygia guttata
BLAST 382 4.00E-54 JG662690
31 R22 1.05 Proteasome (prosome,
macropain) 26S subunit,
ATPase,1 (PSMC1)-Gallus
gallus
BLAST 324 4.00E-133 JG662691
32 R99 1.04 Gallus gallus hypothetical
protein
BLAST 362 2.00E-86 JG662692
33 R2 1.04 Ribosomal protein L35a-
Gallus gallus
BLAST 90 3.00E-08 JG662693
34 R36 1.04 Gallus gallus finished cDNA,
clone ChEST191i5
tBLASTx 414 0.025 JG662694
35 R124 1.02 Gallus gallus BAC clone
CH261-189F16 from
chromosome z
BLAST 524 0 JG662695
36 R86 1.02 Transmembrane protein 30A-
Taeniopygia guttata
BLAST 220 4.00E-72 JG662696
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Page 6 of 11Figure 1 Subtractive hybridization cDNA library construction and screening. (A) PDH infected with DHBV, 8 days post-infection. (B) PCR
Confirmation of DHBV infection. Upper lane shows the increase in amplification of a DHBV specific gene from days 1 through 8, while the
amplification is missing from uninfected controls. (C) Comparison of subtracted and unsubtracted cDNAs on a 2% agarose gel. Individual lanes
are marked. Lane 5 is a 100 bp DNA ladder. Lane 8 is a positive control provided with the kit. (D) Analysis of subtraction efficiency using PCR for
GAPDH. (E) Macroarray screening by dot-blot hybridization. Each clone is spotted in duplicates. Membranes were hybridized with radio-labelled
probes as indicated. The average densitometric intensities of each duplicate clone pair was read for relative abundance calculation.
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Page 7 of 11Figure 2 Real-time PCR of representative genes in DHBV infected PDH, 0-day and 4-days post-infection. (A) Significant up-regulation of
cDNAs (F22, F8, and F71) selected from the top of short-listed clones in the up-regulated gene table (Table-1). (B) Significant down-regulation of
cDNAs (R73, R90, and R130) selected from the top of short-listed clones in the down-regulated gene table (Table-2). The Y-axis represents
relative gene expression values obtained from the Pfaffl analysis (see Methods). Significant P-values (< 0.05) are indicated. The values in
parenthesis indicate fold-change in expression.
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Page 8 of 11Table 3 Categorization of genes according to the reported function available from literature
FORWARD REVERSE
Membrane proteins Cadherin 11 Transmembrane protein 30A
Lysosomal-associated membrane protein 1
CD9 protein
Leucine-rich repeats and calponin homology (CH) domain
containing 4
Cellular Respiration Pyruvate dehydrogenase E1-beta subunit Alpha enolase
Succinate-CoA ligase, GDP-forming, alpha subunit(SUCLG1) Hydroxyacyl glutathione hydrolase-like
ATP synthase, H+ transporting, mitochondrial F0 complex,
subunit F2(ATP5J2)
ATPase8, ATPase6 genes for F0-ATP synthase subunit 8, F0-ATP
synthase subunit 6
Cytochrome oxidase subunit I (COI)
Cytoskeletal Filamin B, beta Beta-actin
T-complex 1
Microtubule-associated protein RP/EB family, member 1
Similar to Ankycorbin
Signal Transduction Beta-catenin isolate 3 TRAF interacting protein (TRAIP)
Quaking homolog, KH domain
Transcription and
Translation
High mobility group AT-hook 2 (HMGA2) Splicing factor, arginine/serine-rich 18 (SFRS18)
High-mobility group box 3 MYST/Esa1-associated factor 6
Heat shock transcription factor 2 (HSF2) Y box binding protein 1
CWC22 spliceosome-associated protein homolog Ribosomal protein L35a
Ubiquitin-like, containing PHD and RING finger domains, 1
(UHRF1)
Eukaryotic translation initiation factor 5 (EIF5)
Nuclear protein Matrin 3 (MATR3)
Ribosomal protein L6 (RPL6)
Ribophorin I
Ubiquitin-
proteasome
Ubiquitin specific peptidase 47 (USP47) Proteasome (prosome, macropain) 26S subunit, ATPase,1
(PSMC1)
Sequestosome 1
Apoptosis Tumor necrosis factor receptor superfamily, member 6b,
decoy (TNFRSF6B)
Caspase 3, apoptosis-related cysteine peptidase (CASP3)
Others Anas platyrhynchos female-specific sequence No significant similarity found
Junco hyemalis 164 gene, partial sequence UPF0308 protein
Gallus gallus finished cDNA, clone ChEST457d18 No significant similarity found
No significant similarity found Gallus gallus finished cDNA, clone ChEST757h13
Gallus gallus finished cDNA, clone ChEST855m19 Gallus gallus finished cDNA, clone ChEST191i5
Zebrafish DNA sequence from clone CH211-276C22 in
linkage group 6
Gallus gallus BAC clone CH261-189F16 from chromosome z
Similar to SH3 domain containing 19 Gallus gallus hypothetical protein
Zinc finger CCCH-type containing 13 (ZC3H13) Gallus gallus similar to MGC53471 protein
ElaC homolog 2 (E. coli) (ELAC2) Ferritin, heavy polypeptide 1 (FTH1)
Similar to KIAA2019 protein/AHNAK nucleoprotein 2 Zinc finger CCCH-type, antiviral 1 (ZC3HAV1)
CLE7 Similar to RGD-CAP
Cu/Zn superoxide dismutase (SOD1) Versican
Exonuclease NEF-sp Platelet-activating factor acetylhydrolase isoform Ib, alpha
subunit 45kDa (PAFAH1B1)
Component of oligomeric golgi complex 3 (COG3) Catechol-O-methyltransferase
Clathrin, light chain A (CLTA) Chromosome 15 hypothetical ATG/GTP binding protein
RAB 32, member of Ras oncogene Ankyrin repeat domain 17 (ANKRD17)
Holocytochrome c synthase (cytochrome c heme-lyase) Similar to KIAA1824 protein/WD repeat domain 22
Serine protease 23 Ral guanine nucleotide dissociation stimulator-like 1 (RGL1)
Leucine proline-enriched proteoglycan (leprecan)1/prolyl 3-
hydroxylase 1 (P3H1)
Acid alpha-glucosidase
Spastic paraplegia 3A (autosomal dominant)
Alanine-glyoxylate aminotransferase 2
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Page 9 of 11in transcription/translation (19%), whereas the ones
maximum down regulated (11%) belonged to cytoskele-
tal proteins. The former included the HMG Box pro-
teins and Y-box binding proteins. Previous studies have
implicated the Y-box binding protein1, Platelet-activat-
ing factor acetylhydrolase isoform 1B (PAFAH1B1),
Ribosomal Protein L35a, Ferritin, a-enolase, Caspase 3,
CuZn Superoxide Dismutase (CuZnSOD), Filamin B,
Pyruvate dehydrogenase 1-b, b-catenin, prolyl-3-hydro-
xylase 1, b-actin, acid a-glucosidase, and clathrin, the
cDNAs of which were identified to be up-regulated,
with chronic HBV infections and HCC development
[6,15-26]. In comparison to the earlier report based on
proteome analysis in DHBV infected PDH [8], except
for b-actin and a-enolase, all the cDNAs identified in
the present study represented new genes. The difference
could be due to multiple reasons, and importantly it
might include the selective enrichment/elimination of
some of the cDNAs during the process of RT-PCR
amplification and cloning as part of the subtraction
library construction. Nevertheless, our data provides a
new set of candidate genes worth further investigation
in hepadnaviral infection.
An interesting observation in this study was the inverse
pattern of differential expression of ten of these genes in
in vitro DHBV infected cells as against the reports on
HCC clinical samples [6,15-20]. The mRNAs for the Y-
box binding protein1, PAFAH1B1, Ribosomal Protein
L35a, Ferritin, a-enolase, acid alpha-glucosidase and Cas-
pase 3 were shown to be down-regulated during in vitro
DHBV infection, whereas those of CuZnSOD, Filamin B
and Pyruvate dehydrogenase were shown to be up-regu-
lated, where as the reverse was the trend in human HCC.
This observation may be purely coincidental owing to the
fact that the experimental method we used was an in vitro
system, and the changes in primary hapatocytes during
culture itself, such as de-differentiation, might have led to
these alterations in gene expression.
Conclusions
In summary, the present study identified cDNAs of a
number of genes that are differentially modulated in cul-
tured PDH, invitro infected with DHBV. cDNAs of both
novel as well as already reported genes/proteins asso-
ciated with HBV/DHBV infection or HCC were identi-
fied in the library. The genes short-listed here could be
valuable leads for further studies in animal models,
which might help to understand the pathology of
chronic HBV infections and pathogenesis of HCC.
Additional material
Additional file 1: Primers used in the study.
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